Attovia Therapeutics short interest
$18.16+2.89%
Close Sep 29, 2026 · split-adjustedShares short831.1KSettled Sep 15, 2026
Change+28.1%from 648.5K
% of float3.2%Float 25.9M shares
Days to cover4.0Short volume 62.6% (10d)
Shares sold short by settlement
Settlement history
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| Sep 15, 2026 | 831.1K | +28.1% | 4.0 |
| Aug 31, 2026 | 648.5K | +26.7% | 3.1 |
| Aug 14, 2026 | 511.9K | +573.4% | 1.0 |
| Jul 14, 2023 | 76.0K | −31.4% | 1.0 |
| Jun 30, 2023 | 110.9K | +14.1% | 1.1 |
| Jun 15, 2023 | 97.1K | −34.1% | 1.0 |
| May 31, 2023 | 147.5K | +9205.6% | 1.0 |
| May 15, 2023 | 1.6K | −62.5% | 1.0 |
| Apr 28, 2023 | 4.2K | +4.5% | 1.3 |
| Apr 14, 2023 | 4.0K | −34.5% | 1.0 |
| Mar 31, 2023 | 6.2K | +12.7% | 1.0 |
| Mar 15, 2023 | 5.5K | — | 1.0 |
Reading these numbers
Short interest is the number of shares sold short and not yet repurchased, reported by FINRA twice a month with a delay of about two weeks. As a share of float it shows how crowded the bet against Attovia Therapeutics is — 3.2% here; days to cover estimates how long buying those shares back would take at average volume. Compare it with the short squeeze monitor or learn more in our short interest guide.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology